NOV 19, 2015 7:00 AM PST

WEBINAR: Glycated Hemoglobin (HbA1c) for Diagnosis and Monitoring of Diabetes: Current Practice

Speakers

Abstract
DATE: November 19, 2015
TIME: 7:00AM Pacific, 9:00AM Central, 10:00AM Eastern, 3:00PM GMT

Diabetes represents a serious global epidemic.  Diabetes causes its own direct adverse effects but also predisposes patients to the development of both cardiovascular disease (CVD) and chronic kidney disease (CKD).  Identifying individuals at risk of developing diabetes and monitoring glycemic control of patients with the disease are medical imperatives.  Glycated hemoglobin (HbA1c) is a marker well established and routinely used for the monitoring of long term glycemia.  Improvements in the analytical performance of HbA1c assays now allow the test to be effectively used for risk assessment in order to prevent individuals from developing the disease.  Traditional methods such as fasting blood glucose, two-hour postprandial glucose, and the glucose tolerance test continue to be used for diagnosis but HbA1c offers unique advantages (e.g., no need for a fasting sample, reflect the average blood glucose of a three month period, etc.). 


Since the late 1970’s large numbers of HbA1c methods have been introduced into clinical practice, but there was obviously a significant difference in the results produced by different laboratories. Lack of standardization resulted in several countries developing National Standardization Programs including US (NGSP; National Glycohemoglobin Standardization Program), Japan and Sweden. The IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) implemented the international standardization for HbA1c.  Significant work has been done by each of these standardization programs and there remains a need to implement a harmonized procedure for reporting HbA1c measurements. 

 

During today’s webcast, we will learn about the nature of HbA1c formation, the outcomes of standardization efforts, and the quality of its measurements which are key to its use in clinical practice for either monitoring or diagnosis.

Who Should Attend:

  • Laboratorians
  • Endocrinologists
  • Clinicians
  • Metabolic Specialists

Learning Objectives:

  • Understand how and why glycated hemoglobin (HbA1c) is formed.
  • Explain how the concentration of HbA1c corresponds to a patients glycemic control (average blood glucose concentration).
  • Identify the adverse effects of diabetes.
  • Compare and contrast the traditional means of diagnosing diabetes (fasting blood glucose, two hour postprandial glucose, and glucose tolerance test) with HbA1c.
  • Describe the international reference measurement system (RMS) for HbA1c.

Attend and receive FREE CE credits!

ADD-00056531

Show Resources
You May Also Like
SEP 28, 2022 9:00 AM PDT
SEP 28, 2022 9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
NOV 16, 2022 8:00 AM PST
C.E. CREDITS
NOV 16, 2022 8:00 AM PST
Date: November 16, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope spe...
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
NOV 01, 2022 10:00 AM PDT
NOV 01, 2022 10:00 AM PDT
Date: November 01, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 6:00pm (CET) Our laboratory developed the Pig-a gene mutation assay as a means to simply and reliably evaluate the potential mutage...
Loading Comments...
Show Resources